SK18152000A3 - Cyklopentanóndihydropyridínové zlúčeniny účinné ako látky otvárajúce draslíkové kanály - Google Patents

Cyklopentanóndihydropyridínové zlúčeniny účinné ako látky otvárajúce draslíkové kanály Download PDF

Info

Publication number
SK18152000A3
SK18152000A3 SK1815-2000A SK18152000A SK18152000A3 SK 18152000 A3 SK18152000 A3 SK 18152000A3 SK 18152000 A SK18152000 A SK 18152000A SK 18152000 A3 SK18152000 A3 SK 18152000A3
Authority
SK
Slovakia
Prior art keywords
group
hydrogen
compound
alkyl
haloalkyl
Prior art date
Application number
SK1815-2000A
Other languages
English (en)
Slovak (sk)
Inventor
William A. Carroll
Yiyuan Chen
Irene Drizin
James F. Kerwin
Jimmie L. Moore
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of SK18152000A3 publication Critical patent/SK18152000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SK1815-2000A 1999-03-04 2000-03-06 Cyklopentanóndihydropyridínové zlúčeniny účinné ako látky otvárajúce draslíkové kanály SK18152000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/262,441 US6518279B2 (en) 1999-03-04 1999-03-04 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
PCT/US2000/005828 WO2000051986A1 (en) 1999-03-04 2000-03-06 Cyclopentanone dihydropyridine compounds useful as potassium channel openers

Publications (1)

Publication Number Publication Date
SK18152000A3 true SK18152000A3 (sk) 2001-06-11

Family

ID=22997528

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1815-2000A SK18152000A3 (sk) 1999-03-04 2000-03-06 Cyklopentanóndihydropyridínové zlúčeniny účinné ako látky otvárajúce draslíkové kanály

Country Status (20)

Country Link
US (1) US6518279B2 (pt)
EP (1) EP1075466A1 (pt)
JP (1) JP2003517454A (pt)
KR (1) KR20010043295A (pt)
CN (1) CN1318053A (pt)
AR (1) AR028987A1 (pt)
AU (1) AU3616800A (pt)
BG (1) BG104999A (pt)
BR (1) BR0005189A (pt)
CA (1) CA2330541A1 (pt)
CO (1) CO5150208A1 (pt)
HU (1) HUP0102895A3 (pt)
IL (1) IL139140A0 (pt)
MX (1) MXPA00010790A (pt)
NO (1) NO20005570L (pt)
PL (1) PL343883A1 (pt)
SK (1) SK18152000A3 (pt)
TR (1) TR200003202T1 (pt)
WO (1) WO2000051986A1 (pt)
ZA (1) ZA200005798B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US7074931B2 (en) 2000-08-02 2006-07-11 Astrazeneca Ab Process for asymmetric synthesis of substituted 1,4 -dihydropyridines
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US20030199578A1 (en) * 2002-04-19 2003-10-23 Turner Sean C. Naphthalene amides as potassium channel openers
JP2009526079A (ja) 2006-02-10 2009-07-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ カリウムチャンネル開放物質としての新規な三環式ジヒドロピラジン
JP5638011B2 (ja) 2009-02-18 2014-12-10 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 二および三環式インダゾール置換１，４−ジヒドロピリジン誘導体およびそれらの使用
WO2021253180A1 (en) * 2020-06-15 2021-12-23 Novartis Ag Methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-4, 5, 6, 7-tetrahydro-1h-cyclopenta [b] pyridine-3-carboxylate and methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-1, 4, 5, 7-tetrahydrofuro [3, 4-b] pyridine-3-carboxylate as cav1.2 activators
US11939316B1 (en) 2023-11-06 2024-03-26 King Faisal University 9-(6-flouro-2-hydroxyouinolin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexhydroacridine-1,8(2h,5h)-dione as an antimicrobial compound
US11970478B1 (en) 2023-11-16 2024-04-30 King Faisal University 9-(2-hydroxyquinolin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
DE3447170A1 (de) 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8716971D0 (en) 1987-07-17 1987-08-26 Pfizer Ltd Therapeutic agents
GB8907401D0 (en) 1989-04-01 1989-05-17 Pfizer Ltd Therapeutic agents
ATE161531T1 (de) 1991-10-21 1998-01-15 Zeneca Ltd Acridine-1,8-dionderivate als therapeutisches mittel
GB9220570D0 (en) 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
GB9318935D0 (en) 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
DE4313690A1 (de) 1993-04-27 1994-11-03 Bayer Ag Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
WO1999031059A1 (en) 1997-12-18 1999-06-24 Abbott Laboratories Potassium channel openers

Also Published As

Publication number Publication date
WO2000051986A1 (en) 2000-09-08
US20020007065A1 (en) 2002-01-17
PL343883A1 (en) 2001-09-10
MXPA00010790A (es) 2002-06-04
AU3616800A (en) 2000-09-21
HUP0102895A3 (en) 2002-01-28
CA2330541A1 (en) 2000-09-08
EP1075466A1 (en) 2001-02-14
CO5150208A1 (es) 2002-04-29
NO20005570D0 (no) 2000-11-03
AR028987A1 (es) 2003-06-04
BR0005189A (pt) 2001-01-09
JP2003517454A (ja) 2003-05-27
BG104999A (en) 2001-10-31
HUP0102895A2 (hu) 2001-12-28
NO20005570L (no) 2000-11-03
ZA200005798B (en) 2002-01-18
IL139140A0 (en) 2001-11-25
TR200003202T1 (tr) 2001-08-21
US6518279B2 (en) 2003-02-11
CN1318053A (zh) 2001-10-17
KR20010043295A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
EP1611133B1 (en) Condensed n-heterocyclic compound and use thereoff as crf receptor antagonist
CA2158632C (en) Catechol diether compounds as inhibitors of tnf release
AU2009331179B2 (en) Novel bicyclic heterocyclic compound
JPH06505715A (ja) 化合物
TW202214610A (zh) ６－側氧－３，６－二氫吡啶類衍生物、其製備方法及其在醫藥上的應用
KR20050083918A (ko) Ｇｓｋ-3베타 억제제로서의 피리다지논 유도체
AU716435B2 (en) Novel indole-2,3-dione-3-oxime derivatives
SK12332003A3 (sk) Tiohydantoíny a ich použitie na liečenie cukrovky
KR20060123651A (ko) 신경퇴행성 장애 치료용 이미다졸 화합물
WO2005115984A2 (en) Large conductance calcium-activitated k channel opener
KR970005302B1 (ko) 이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제
WO2021249519A1 (zh) 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用
SK18152000A3 (sk) Cyklopentanóndihydropyridínové zlúčeniny účinné ako látky otvárajúce draslíkové kanály
JP2529798B2 (ja) ４−ピリミジノン誘導体、その製造方法および治療への適用
JPS60214778A (ja) Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
CA1330663C (en) Thiazolidinedione derivatives
CN114478537B (zh) 环酰胺并环化合物及其医药用途
SK5242001A3 (en) Pyrano-, piperidino- and thiopyrano compounds and methods of use
CZ20004428A3 (cs) Cyklopentanon dihydropyridinové sloučeniny užitečné jako látky otevírající draslíkové kanály
US7057047B2 (en) Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2oxo-hexyl)-1-isoidolinone
US6274587B1 (en) Tricyclic dihydropyrimidine potassium channel openers
US5475114A (en) Pyrazolotriazole derivatives
HU191597B (en) Process for producing of 2-/2-indalin/-imadazoline preparates and medical preparates consisting of such substances
JPS6377875A (ja) ヘテロ環式置換インドリノン、その製法並びにこれを含有する心臓−及び循環系疾患治療剤
TW202419090A (zh) Nlrp3炎症小體抑制劑及其應用